论文部分内容阅读
目的:探讨DSG—I型肝病治疗仪在降低慢性乙型病毒性肝炎生化指标速度,减少病毒复制及减轻患者痛苦的作用。方法:将204例乙肝患者随机分为观察组和对照组各102例,观察组应用DSG—I型肝病治疗仪联合药物治疗慢性乙型肝炎与对照组单纯药物治疗进行疗效对比观察。结果:观察组比对照组在相同住院条件下ALT、AST的下降幅度明显增加。观察组平均下降391.5U/L,对照组平均289.2U/L,P<0.05。结论:DSG-I型肝病治疗仪配合药物治疗慢性乙型肝炎对改善临床症状、恢复肝功能有一定的作用,能缩短患者的住院时间,减轻患者的病痛,提高生活质量。
Objective: To investigate the effect of DSG-I therapeutic device on reducing the biochemical index of chronic hepatitis B, reducing virus replication and alleviating the pain of patients. Methods: A total of 204 patients with hepatitis B were randomly divided into observation group and control group, 102 cases in each group. The observation group was treated with DSG-I hepatopathy treatment instrument combined with drug treatment of chronic hepatitis B and the control group of simple drug treatment comparison. Results: The decrease of ALT and AST in observation group was significantly higher than that in control group under the same hospitalization conditions. The observation group average decreased 391.5U / L, the control group average 289.2U / L, P <0.05. Conclusion: Treatment of chronic hepatitis B with DSG-I treatment with drugs can improve clinical symptoms and restore liver function. It can shorten the hospitalization time, alleviate the patient’s pain and improve the quality of life.